Related references
Note: Only part of the references are listed.2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Association of Nonfasting vs Fasting Lipid Levels With Risk of Major Coronary Events in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm
Samia Mora et al.
JAMA INTERNAL MEDICINE (2019)
Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids
Kamil F. Faridi et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Comparison of non-fasting LDL-C levels calculated by Friedewald formula with those directly measured in Chinese patients with coronary heart disease after a daily breakfast
Qiu-zhen Lin et al.
CLINICA CHIMICA ACTA (2019)
Changes in non-fasting concentrations of blood lipids after a daily Chinese breakfast in overweight subjects without fasting hypertriglyceridemia
Feng Tian et al.
CLINICA CHIMICA ACTA (2019)
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
Pratik B. Sandesara et al.
ENDOCRINE REVIEWS (2019)
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial
Antonio J. Vallejo-Vaz et al.
CIRCULATION (2018)
Update on the laboratory investigation of dyslipidemias
I. Ramasamy
CLINICA CHIMICA ACTA (2018)
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Michel R. Langlois et al.
CLINICAL CHEMISTRY (2018)
A Test in Context: Lipid Profile, Fasting Versus Nonfasting
Borge G. Nordestgaard
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Indispensable role of lipoprotein bound-ApoE in adipogenesis and endocytosis induced by postprandial TRL
Mingyu Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Risk of misclassification with a non-fasting lipid profile in secondary cardiovascular prevention
Boudewijn Klop et al.
CLINICA CHIMICA ACTA (2017)
Positioning about the Flexibility of Fasting for Lipid Profiling
Marileia Scartezini et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2017)
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
Todd J. Anderson et al.
CANADIAN JOURNAL OF CARDIOLOGY (2016)
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2016)
Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2014 US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline
John R. Downs et al.
ANNALS OF INTERNAL MEDICINE (2015)
Postprandial decrease in LDL-cholesterol in men with metabolic syndrome
Anna Skoczynska et al.
OPEN MEDICINE (2015)
Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality Insight From the National Health and Nutrition Examination Survey III (NHANES-III)
Bethany Doran et al.
CIRCULATION (2014)
Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation
Anette Varbo et al.
CIRCULATION (2013)
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Anette Varbo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Fasting Time and Lipid Levels in a Community-Based Population A Cross-sectional Study
Davinder Sidhu et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Nonfasting Lipids, Lipoproteins, and Apolipoproteins in Individuals with and without Diabetes: 58 434 Individuals from the Copenhagen General Population Study
Anne Langsted et al.
CLINICAL CHEMISTRY (2011)
Circulating Proprotein Convertase Subtilisin Kexin Type 9 Has a Diurnal Rhythm Synchronous With Cholesterol Synthesis and Is Reduced by Fasting in Humans
Lena Persson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Fasting and Nonfasting LDL Cholesterol: To Measure or Calculate?
Borge G. Nordestgaard et al.
CLINICAL CHEMISTRY (2009)
Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein
Paul J. W. H. Kappelle et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Dyslipidemia in type 2 diabetes mellitus
Arshag D. Mooradian
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2009)
Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events
Samia Mora et al.
CIRCULATION (2008)
Fasting and Nonfasting Lipid Levels Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction
Anne Langsted et al.
CIRCULATION (2008)
Sustained postprandial decrease in plasma levels of LDL cholesterol in patients with type-2 diabetes mellitus
S. S. Lund et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2008)
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Sandeep Bansal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations
RPF Dullaart et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2004)
Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes
FV van Venrooij et al.
DIABETES CARE (2003)
Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease
EJ Schaefer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Cholesteryl ester transfer and cholesterol esterification in type 1 diabetes: relationships with plasma glucose
CK Chang et al.
ACTA DIABETOLOGICA (2001)
Share Paper
